0001209191-19-021457.txt : 20190327
0001209191-19-021457.hdr.sgml : 20190327
20190327173413
ACCESSION NUMBER: 0001209191-19-021457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190325
FILED AS OF DATE: 20190327
DATE AS OF CHANGE: 20190327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stephenson Pamela
CENTRAL INDEX KEY: 0001767650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33451
FILM NUMBER: 19709252
MAIL ADDRESS:
STREET 1: C/O ZYNERBA PHARMACEUTICALS, INC.
STREET 2: 80 W. LANCASTER AVENUE, SUITE 300
CITY: DEVON
STATE: PA
ZIP: 19333
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALBIREO PHARMA, INC.
CENTRAL INDEX KEY: 0001322505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 857-415-4774
MAIL ADDRESS:
STREET 1: 10 POST OFFICE SQUARE
STREET 2: SUITE 502 SOUTH
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Biodel Inc
DATE OF NAME CHANGE: 20050331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-25
0
0001322505
ALBIREO PHARMA, INC.
ALBO
0001767650
Stephenson Pamela
C/O ALBIREO PHARMA, INC.
10 POST OFFICE SQUARE, SUITE 502 SOUTH
BOSTON
MA
02109
0
1
0
0
Chief Commercial Officer
Common Stock
2019-03-25
4
A
0
25000
0.00
A
25000
D
Stock Option (right to buy)
28.76
2019-03-25
4
A
0
37500
0.00
A
2029-03-24
Common Stock
37500
37500
D
Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest as to 25% of the shares on March 25, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on June 25, 2020 and ending on March 25, 2023.
This option vests as to 25% of the shares on March 25, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on June 25, 2020 and ending on March 25, 2023.
/s/ Jason Duncan, Attorney-in-fact
2019-03-27